The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A
Open accessAbstract
Cell cycle exit is required for proper differentiation in most cells and is critical for normal development, tissue homeostasis, and tumor suppression. However, the mechanisms that link cell cycle exit with differentiation remain poorly understood. Here, we show that the master melanocyte differentiation factor, microphthalmia transcription factor (MITF), regulates cell cycle exit by activating the cell cycle inhibitor INK4A, a tumor suppressor that frequently is mutated in melanomas. MITF binds the INK4A promoter, activates p16Ink4a mRNA and protein expression, and induces retinoblastoma protein hypophosphorylation, thereby triggering cell cycle arrest. This activation of INK4A was required for efficient melanocyte differentiation. Interestingly, MITF was also required for maintaining INK4A expression in mature melanocytes, creating a selective pressure to escape growth inhibition by inactivating INK4A. These findings demonstrate that INK4A can be regulated by a differentiation factor, establish a mechanistic link between melanocyte differentiation and cell cycle exit, and potentially explain the tissue-specific tendency for INK4A mutations to occur in melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Principles of Tumor Suppression
Sherr, C. J. (2004) · Cell · doi:10.1016/s0092-8674(03)01075-4 · Cited by 1,034
McGill, G. G., Horstmann, M., Widlund, H. R., Du, J., Motyckova, G., Nishimura, E. K., Lin, Y.-L., Ramaswamy, S., Avery, W., Ding, H.-F., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00762-6 · Cited by 760
Kitagawa, M., Higashi, H., Jung, H. K., Suzuki-Takahashi, I., Ikeda, M., Tamai, K., Kato, J., Segawa, K., Yoshida, E., Nishimura, S., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01097.x · Cited by 589
The retinoblastoma gene family in differentiation and development
Lipinski, M. M., & Jacks, T. (1999) · Oncogene · doi:10.1038/sj.onc.1203244 · Cited by 405
Widlund, H. R., & Fisher, D. E. (2003) · Oncogene · doi:10.1038/sj.onc.1206443 · Cited by 371
Mutations associated with familial melanoma impair p16INK4 function
Ranade, K., Hussussian, C. J., Sikorski, R. S., Varmus, H. E., Goldstein, A. M., Tucker, M. A., Serrano, M., Hannon, G. J., Beach, D., & Dracopoli, N. C. (1995) · Nature Genetics · doi:10.1038/ng0595-114 · Cited by 280 · cited 2×
“The direct link between MITF and INK4A provides an attractive explanation for the strong association between INK4A mutation and melanoma ( Ranade et al., 1995; Monzon et al., 1998).”
BackgroundBrugarolas, J., Moberg, K., Boyd, S. D., Taya, Y., Jacks, T., & Lees, J. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.1002 · Cited by 276
CDKN2A Mutations in Multiple Primary Melanomas
Monzon, J., Liu, L., Brill, H., Goldstein, A. M., Tucker, M. A., From, L., McLaughlin, J., Hogg, D., & Lassam, N. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381305 · Cited by 264
Tachibana, M., Takeda, K., Nobukuni, Y., Urabe, K., Long, J. E., Meyers, K. A., Aaronson, S. A., & Miki, T. (1996) · Nature Genetics · doi:10.1038/ng0996-50 · Cited by 257
Ikeda, M. A., Jakoi, L., & Nevins, J. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3215 · Cited by 246
Cell proliferation inhibited by MyoD1 independently of myogenic differentiation
Sorrentino, V., Pepperkok, R., Davis, R. L., Ansorge, W., & Philipson, L. (1990) · Nature · doi:10.1038/345813a0 · Cited by 219
Malignant melanoma: modern black plague and genetic black box
Chin, L., Merlino, G., & DePinho, R. A. (1998) · Genes & Development · doi:10.1101/gad.12.22.3467 · Cited by 194
p16Ink4a in Melanocyte Senescence and Differentiation
Sviderskaya, E. V. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.6.446 · Cited by 179
Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.
van der Velden, P. A., Metzelaar-Blok, J. A. W., Bergman, W., Monique, H., Hurks, H. M. H., Frants, R. R., Gruis, N. A., & Jager, M. J. (2001) · PubMed · Cited by 147
Yavuzer, U., Keenan, E., Lowings, P., Vachtenheim, J., Currie, G., & Goding, C. R. (1995) · PubMed · Cited by 128
Takebayashi, K., Chida, K., Tsukamoto, I., Morii, E., Munakata, H., Arnheiter, H., Kuroki, T., Kitamura, Y., & Nomura, S. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1203 · Cited by 111
Béjar, J., Hong, Y., & Schartl, M. (2003) · Development · doi:10.1242/dev.00872 · Cited by 106
Transducible Peptide Therapy for Uveal Melanoma and Retinoblastoma
Harbour, J. W. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.10.1341 · Cited by 98
Self-citationYasumoto, K., Mahalingam, H., Suzuki, H., Yoshizawa, M., Yokoyama, K., & Shibahara, S. (1995) · The Journal of Biochemistry · doi:10.1093/jb/118.5.874 · Cited by 71
Distinct Mechanisms for Regulating the Tumor Suppressor and Antiapoptotic Functions of Rb
Ma, D., Zhou, P., & Harbour, J. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301761200 · Cited by 64
Self-citationYu, B., Becker‐Hapak, M., Snyder, E. L., Vooijs, M., Denicourt, C., & Dowdy, S. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2431391100 · Cited by 41
Kästner, A., Espanel, X., & Brun, G. (1998) · PubMed · Cited by 16
Cited by
Garraway, L. A., Widlund, H. R., Rubin, M. A., Getz, G., Berger, A. J., Ramaswamy, S., Beroukhim, R., Milner, D. A., Granter, S. R., Du, J., et al. (2005) · Nature · doi:10.1038/nature03664 · Cited by 1,548
MITF: master regulator of melanocyte development and melanoma oncogene
Levy, C., Khaled, M., & Fisher, D. E. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.07.008 · Cited by 1,169
Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843
In vivo Switching of Human Melanoma Cells between Proliferative and Invasive States
Hoek, K. S., Eichhoff, O. M., Schlegel, N. C., Döbbeling, U., Kobert, N., Schaerer, L., Hemmi, S., & Dummer, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2491 · Cited by 743
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Müller, J., Krijgsman, O., Tsoi, J., Robert, L., Hugo, W., Song, C., Kong, X., Possik, P. A., Cornelissen-Steijger, P. D. M., Foppen, M. H. G., et al. (2014) · Nature Communications · doi:10.1038/ncomms6712 · Cited by 639
Metadata
- Authors
- Loercher, A. E., Tank, E. M. H., Delston, R. B., & Harbour, J. W.
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2004-12-28
- Volume
- 168
- Issue
- 1
- Pages
- 35-40
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- OpenAlex
- W2164134009
- Cited by
- 266
- References
- 23
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.